Drugs / Florbetapir F 18 (18F-AV-45)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01606488 | May 2012 → Jun 2026 overdue | — | University of California, San Francisco | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Florbetapir F 18 (18F-AV-45) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01606488 ↗ |
| Route | Intravenous | “Single IV bolus injection of 370 MBq (10mCi) florbetapir will be administered approximately 50 minutes prior to a 10 minute PET scan.” NCT01606488 ↗ |